Search Results - "Noji, Shinobu"

A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 by Tamura, Ryota, Fujioka, Masato, Morimoto, Yukina, Ohara, Kentaro, Kosugi, Kenzo, Oishi, Yumiko, Sato, Mizuto, Ueda, Ryo, Fujiwara, Hirokazu, Hikichi, Tetsuro, Noji, Shinobu, Oishi, Naoki, Ogawa, Kaoru, Kawakami, Yutaka, Ohira, Takayuki, Yoshida, Kazunari, Toda, Masahiro

“…The anti-VEGF antibody bevacizumab has shown efficacy for the treatment of neurofibromatosis type 2 (NF2). Theoretically, vascular endothelial growth factor…”
Get full text

Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors by Hirai, Ikuko, Funakoshi, Takeru, Kamijuku, Hajime, Fukuda, Keitaro, Mori, Mariko, Sakurai, Masatoshi, Koda, Yuya, Kato, Jun, Mori, Takehiko, Watanabe, Naohide, Noji, Shinobu, Yaguchi, Tomonori, Iwata, Takashi, Ohta, Shigeki, Fujita, Tomonobu, Tanosaki, Ryuji, Handa, Makoto, Okamoto, Shinichiro, Amagai, Masayuki, Kawakami, Yutaka

“…To evaluate the feasibility of adoptive cell therapy (ACT) using ex vivo‐expanded tumor‐infiltrating lymphocytes (TILs) in Japanese patients with melanoma who…”
Get full text

Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series by Tamura, Ryota, Morimoto, Yukina, Kosugi, Kenzo, Sato, Mizuto, Oishi, Yumiko, Ueda, Ryo, Kikuchi, Ryogo, Nagashima, Hideaki, Hikichi, Tetsuro, Noji, Shinobu, Kawakami, Yutaka, Sasaki, Hikaru, Yoshida, Kazunari, Toda, Masahiro

“…The expression of vascular endothelial growth factor (VEGF)-A/ VAGF receptors (VEGFRs) signaling plays a pivotal role in the tumor angiogenesis and the…”
Get full text

Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 by Tamura, Ryota, Fujioka, Masato, Morimoto, Yukina, Ohara, Kentaro, Kosugi, Kenzo, Oishi, Yumiko, Sato, Mizuto, Ueda, Ryo, Fujiwara, Hirokazu, Hikichi, Tetsuro, Noji, Shinobu, Oishi, Naoki, Ogawa, Kaoru, Kawakami, Yutaka, Ohira, Takayuki, Yoshida, Kazunari, Toda, Masahiro

“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text

Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series by Tamura, Ryota, Morimoto, Yukina, Kosugi, Kenzo, Sato, Mizuto, Oishi, Yumiko, Ueda, Ryo, Kikuchi, Ryogo, Nagashima, Hideaki, Hikichi, Tetsuro, Noji, Shinobu, Kawakami, Yutaka, Sasaki, Hikaru, Yoshida, Kazunari, Toda, Masahiro

“…Following publication of the original article [1], the authors reported an error in the author group…”
Get full text

Cancer‐testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer by Okabayashi, Koji, Fujita, Tomonobu, Miyazaki, Junichiro, Okada, Tsutomu, Iwata, Takashi, Hirao, Nobumaru, Noji, Shinobu, Tsukamoto, Nobuo, Goshima, Naoki, Hasegawa, Hirotoshi, Takeuchi, Hiroya, Ueda, Masakazu, Kitagawa, Yuko, Kawakami, Yutaka

“…Esophageal squamous cell cancer (ESCC) is one of the most common lethal tumors in the world, and development of new diagnostic and therapeutic methods is…”
Get full text

Biomarkers for cancer immunotherapy by Kawakami, Yutaka, Kawase, Yoshie, Ohizumi, Azusa, Noji, Shinobu, Sakurai, Toshiharu, Fujita, Tomonobu

“…Immune-biomarkers and -assays are important for development of cancer immunotherapy to select the patients who are expected to respond to immunotherapy before…”
Get more information

Three‐dimensional adipofascial and dermal structures involved in forehead crease formation by Takaya, Kento, Sakamoto, Yoshiaki, Noji, Shinobu, Imanishi, Nobuaki, Kishi, Kazuo

“…Deeply etched forehead creases indicate aging. Various treatments such as filler injections, fat grafting, and facelift surgery are used to remove them…”
Get full text

Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma by Kinoshita, Tomonari, Kudo-Saito, Chie, Muramatsu, Reiko, Fujita, Tomonobu, Saito, Miyuki, Nagumo, Haruna, Sakurai, Toshiharu, Noji, Shinobu, Takahata, Emi, Yaguchi, Tomonori, Tsukamoto, Nobuo, Hayashi, Yuichiro, Kaseda, Kaoru, Kamiyama, Ikuo, Ohtsuka, Takashi, Tomizawa, Kenji, Shimoji, Masaki, Mitsudomi, Tetsuya, Asamura, Hisao, Kawakami, Yutaka

“…We have previously demonstrated that the prognostic significance of tumour-infiltrating CD8+ T cells significantly differs according to histological type and…”
Get full text

Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis by Tamura, Ryota, Yamanobe, Yoshiharu, Fujioka, Masato, Morimoto, Yukina, Fukumura, Mariko, Nakaya, Masato, Oishi, Yumiko, Sato, Mizuto, Ueda, Ryo, Fujiwara, Hirokazu, Hikichi, Tetsuro, Noji, Shinobu, Oishi, Naoki, Ozawa, Hiroyuki, Ogawa, Kaoru, Kawakami, Yutaka, Ohira, Takayuki, Yoshida, Kazunari, Toda, Masahiro

“…The humanized antivascular endothelial growth factor (VEGF) antibody bevacizumab (Bev) is efficacious for the treatment of NF2-related schwannomatosis (NF2),…”
Get full text

A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma by Shibao, Shunsuke, Ueda, Ryo, Saito, Katsuya, Kikuchi, Ryogo, Nagashima, Hideaki, Kojima, Atsuhiro, Kagami, Hiroshi, Pareira, Eriel Sandika, Sasaki, Hikaru, Noji, Shinobu, Kawakami, Yutaka, Yoshida, Kazunari, Toda, Masahiro

“…Early-phase clinical studies of glioma vaccines have shown feasibility and encouraging preliminary clinical activity. A vaccine that targets tumor angiogenesis…”
Get full text

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma by Kikuchi, Ryogo, Ueda, Ryo, Saito, Katsuya, Shibao, Shunsuke, Nagashima, Hideaki, Tamura, Ryota, Morimoto, Yukina, Sasaki, Hikaru, Noji, Shinobu, Kawakami, Yutaka, Yoshida, Kazunari, Toda, Masahiro

“…High-grade gliomas (HGGs) carry a dismal prognosis despite current treatments. We previously confirmed the safety and immunogenicity of a vaccine treatment…”
Get full text

Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis by Okada, Takaho, Noji, Shinobu, Goto, Yasufumi, Iwata, Takashi, Fujita, Tomonobu, Okada, Tsutomu, Matsuzaki, Yuriko, Kuwana, Masataka, Hirakata, Michito, Horii, Akira, Matsuno, Seiki, Sunamura, Makoto, Kawakami, Yutaka

“…To identify tumor antigens useful for diagnosis and immunotherapy of patients with pancreatic ductal adenocarcinoma, we applied a SEREX approach with a cDNA…”
Get full text